Healthcare Value Capital as of Sept. 30, 2017
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 10 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tyme Technologies | 21.9 | $11M | 2.1M | 5.28 | |
| Gilead Sciences (GILD) | 21.9 | $11M | 135k | 81.02 | |
| Pfizer (PFE) | 17.9 | $8.9M | 250k | 35.70 | |
| DepoMed | 13.0 | $6.5M | 1.1M | 5.79 | |
| Noveliontherapeuti.. | 12.4 | $6.2M | 881k | 7.03 | |
| D Fluidigm Corp Del (LAB) | 4.6 | $2.3M | 461k | 5.04 | |
| GlaxoSmithKline | 4.1 | $2.0M | 50k | 40.60 | |
| Amarin Corporation (AMRN) | 3.1 | $1.6M | 450k | 3.50 | |
| Proshares Tr ultsh nasd biot | 1.0 | $514k | 25k | 20.56 | |
| Fibrocell Science | 0.1 | $31k | 10k | 3.10 |
